New HearingLife Survey Finds Hearing Challenges Can Mean Missing the Moments That Matter Most
Source: PR Newswire

HearingLife’s survey of U.S. adults aged 60 and older found that 52% had missed or struggled to experience a meaningful moment because they could not hear clearly; the figure was 98% among those who personally experience hearing difficulty. Among respondents aged 60 and older, 73% said public spaces are not designed with hearing accessibility in mind, while 84% had never used technology or an accommodation to hear better in public. The online survey was conducted June 29–July 27, 2026, among 1,950 adults; the national sample of 750 had a ±3.6 percentage-point margin of error.
Analysis
The investable signal is not the prevalence statistic; it is the gap between reported need and low awareness or use of public-venue hearing accommodations. If venues make assistive listening more visible, that could normalize hearing support and indirectly widen the funnel for Demant’s hearing-care clinics and devices. But the survey was commissioned by HearingLife, a Demant business, and measures self-reported experiences—not referrals, purchase intent, conversion, or revenue. Treat it as category marketing, not evidence of a near-term earnings inflection.
Over 1–3 months, look for corroboration in Demant’s U.S. hearing-care activity and management commentary, rather than extrapolating from the survey. Over 6–18 months, broader venue adoption could support category awareness, while also creating value for assistive-audio platforms and device makers beyond traditional hearing aids. The outcome depends on venue investment, interoperability, and whether accommodations lead consumers toward professional care or substitute for it. This release alone does not justify changing exposure to DEMANT; a price move unsupported by operating data would be vulnerable to reversal.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Key Decisions for Investors
- No trade on the survey alone. Keep DEMANT on watch for U.S. clinic traffic, conversion to fitting, hearing-care revenue, and guidance; verify these in company reporting before attributing any improvement to awareness efforts.
- Treat venue accessibility as a 6–18 month adoption theme, not a current earnings catalyst. Track deployment of assistive-listening systems and interoperability in public venues, alongside evidence that users subsequently seek professional care.
- Falsify the positive category thesis if venue adoption remains limited or Demant reports no corresponding improvement in U.S. demand indicators. Conversely, repeated evidence of stronger clinic demand and favorable guidance would support reassessing the exposure.
More News
- AstraZeneca CEO says Summit drug could drive next generation of cancer combinations after $2 billion investment
- BTIG reiterates Vaxcyte stock rating on strong VAX-31 trial data
- Why is NeoGenomics stock sliding today?
- Up 57% since June: this AI-picked pharma stock keeps climbing
- These stocks could benefit from a midterm election shake-up, JPMorgan says
- Vaxcyte shares surge on late-stage vaccine trial success